We previously reported that genetic variants in the mTOR pathway, including MTOR, were associated with increased risk of breast cancer [12, 13], and there was a potential gene-environment interaction that the association for a variant was stronger in obese vs. normal-weight women [13]. The gene discussed is MTOR; the disease is breast carcinoma.